Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients
- PMID: 15738052
- PMCID: PMC2212822
- DOI: 10.1084/jem.20041679
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients
Abstract
Clinical trials have indicated that autologous hematopoietic stem cell transplantation (HSCT) can persistently suppress inflammatory disease activity in a subset of patients with severe multiple sclerosis (MS), but the mechanism has remained unclear. To understand whether the beneficial effects on the course of disease are mediated by lympho-depletive effects alone or are sustained by a regeneration of the immune repertoire, we examined the long-term immune reconstitution in patients with MS who received HSCT. After numeric recovery of leukocytes, at 2-yr follow-up there was on average a doubling of the frequency of naive CD4(+) T cells at the expense of memory T cells. Phenotypic and T cell receptor excision circle (TREC) analysis confirmed a recent thymic origin of the expanded naive T cell subset. Analysis of the T cell receptor repertoire showed the reconstitution of an overall broader clonal diversity and an extensive renewal of clonal specificities compared with pretherapy. These data are the first to demonstrate that long-term suppression of inflammatory activity in MS patients who received HSCT does not depend on persisting lymphopenia and is associated with profound qualitative immunological changes that demonstrate a de novo regeneration of the T cell compartment.
Figures







Similar articles
-
Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again.Tissue Antigens. 2012 Feb;79(2):83-9. doi: 10.1111/j.1399-0039.2011.01820.x. Tissue Antigens. 2012. PMID: 22220718 Review.
-
Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis.Brain. 2004 May;127(Pt 5):996-1008. doi: 10.1093/brain/awh117. Epub 2004 Feb 25. Brain. 2004. PMID: 14985264
-
Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis.Arthritis Rheum. 2005 May;52(5):1555-63. doi: 10.1002/art.21036. Arthritis Rheum. 2005. PMID: 15880600
-
Reconstitution of T-cell compartment after in utero stem cell transplantation: analysis of T-cell repertoire and thymic output.Haematologica. 2004 Apr;89(4):450-61. Haematologica. 2004. PMID: 15075079
-
Estimating thymic function through quantification of T-cell receptor excision circles.Methods Mol Biol. 2007;380:197-213. doi: 10.1007/978-1-59745-395-0_12. Methods Mol Biol. 2007. PMID: 17876095 Review.
Cited by
-
The Cost Effectiveness of Immunoglobulin vs. Hematopoietic Stem Cell Transplantation for CIDP.Front Neurol. 2021 Mar 22;12:645263. doi: 10.3389/fneur.2021.645263. eCollection 2021. Front Neurol. 2021. PMID: 33828522 Free PMC article.
-
Remission of refractory Crohn's disease after autologous hematopoietic stem cell transplantation.Rev Bras Hematol Hemoter. 2015 Mar-Apr;37(2):136-9. doi: 10.1016/j.bjhh.2015.01.002. Epub 2015 Jan 30. Rev Bras Hematol Hemoter. 2015. PMID: 25818827 Free PMC article. No abstract available.
-
Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trial.Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1248-55. doi: 10.1016/j.ijrobp.2010.05.036. Epub 2010 Aug 26. Int J Radiat Oncol Biol Phys. 2011. PMID: 20800376 Free PMC article. Clinical Trial.
-
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity.Brain. 2022 Jun 3;145(5):1711-1725. doi: 10.1093/brain/awac064. Brain. 2022. PMID: 35661859 Free PMC article.
-
Stem Cell-Based Therapies for Inflammatory Bowel Disease.Int J Mol Sci. 2022 Jul 31;23(15):8494. doi: 10.3390/ijms23158494. Int J Mol Sci. 2022. PMID: 35955628 Free PMC article. Review.
References
-
- Muraro, P.A., R. Cassiani Ingoni, and R. Martin. 2003. Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challenges. Curr. Opin. Neurol. 16:299–305. - PubMed
-
- Fassas, A., and V.K. Kimiskidis. 2003. Stem cell transplantation for multiple sclerosis: what is the evidence? Blood Rev. 17:233–240. - PubMed
-
- Burt, R.K., S. Slavin, W.H. Burns, and A.M. Marmont. 2002. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood. 99:768–784. - PubMed
-
- Fassas, A., A. Anagnostopoulos, A. Kazis, K. Kapinas, I. Sakellari, V. Kimiskidis, and A. Tsompanakou. 1997. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant. 20:631–638. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials